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Background:  There  is  accumulating  evidence  that  human  rhinovirus  (HRV)  causes  acute  lower  respiratory
tract  infections  (ALRTI).  Recently,  HRV-C  was  identiﬁed  as  a new  species  of HRV,  but its spectrum  of  clinical
disease  is not  well  understood.
Objectives:  We  investigated  the  molecular  epidemiology,  demographic  and  clinical  characteristics  of  HRVs
among  hospitalized  children  with  ALRIs.
Study design:  One  hundred  and  sixty-ﬁve  nasopharangeal  aspirates  taken  from  children  <5  years  hos-
pitalized  with  ALRTIs  in Serdang  Hospital,  Malaysia,  were  subject  to  reverse  transcriptase-PCR  for  HRV.
Phylogenetic  analysis  on VP4/VP2  and  5′-NCR  regions  was  used  to further  characterize  HRV.  Other  respi-
ratory  viruses  were  also  investigated  using  semi-nested  multiplex  RT-PCR  assay.  Clinical  parameters
were  analyzed  between  HRV,  RSV and IFV-A  mono-infections  and  between  HRV  species.
Results:  HRV  was  detected  in 54  (33%)  patients  for  both  single  (36 samples)  and multiple  (18 samples)
infections,  61.1%  (22/36)  represents  HRV-A  strains  while  the  remaining  14  HRV-C.  Strain  P51was  the  ﬁrst
reported  representative  of HRV98.  The  majority  of the single  HRV  cases  were  in  the  second  half  of infancy;
HRV-C  occurred  among  older  children  compared  with  HRV-A.  HRV  children  were  admitted  signiﬁcantly
earlier  and less  febrile  than  RSV  and  IFV-A  infection.  HRV-C  infected  children  were  more  likely  to  have
rhonchi  and  vomiting  as compared  to HRV-A.  Pneumonia  was the most  common  discharge  diagnosis
followed  by bronchiolitis  and  post-viral  wheeze  in HRV  patients.
Conclusion:  Our study  showed  high  prevalence  of  HRVs  and  detection  of  HRV-C  among  hospitalized
children  with  ALRTIs  in Malaysia.  Analysis  of clinical  parameters  suggested  speciﬁc  features  associated
with HRVs  infections  and  speciﬁc  HRV  groups.. Background
Human rhinoviruses (HRVs), members of the Picornaviridae,
ere ﬁrst isolated in 1956, are the most prevalent human respira-
ory pathogens [1–3]. Recent developments in HRV detection and
lassiﬁcation methods have led to increasing accumulation of HRV
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sequences in genomic databases revealing greater association of
HRVs with serious ALRTIs such as deadly pneumonia [3–7]. The
presence of the new HRV-C strain in severe respiratory disease has
further instilled research interest in the clinical impact, molecular
biology and epidemiology of HRVs.
2. Objectives
As research of HRV is limited [8], especially in Asian developing
countries, this study aims to examine the molecular epidemiology,
the demographic characteristics and clinical features including the
newly discovered HRV-C species, among hospitalized children less
than 5 years of age with ALRTI in Malaysia.
reserved.
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Table 1
Multiple HRV Infections (n = 18).
Pathogens No. %
Total 18 100
HRV  + RSV 11 61.1
HRV  + HMPV 2 11.1
HRV  + PIV-2 1 5.5
HRV  + RSV + HAdV 1 5.572 M.R. Etemadi et al. / Journal of 
. Study design
.1. Clinical assessment
A study was conducted among children more than one-month-
ld and less than 5 years of age with the diagnosis of ALRTI to
he pediatric wards at Hospital Serdang, Selangor, Malaysia, from
une 16 to December 21, 2009, after obtaining approval from both
he Medical Research and Ethics committee (MREC) of the Min-
stry of Health Malaysia and University Putra Malaysia. Selection
f subjects was based on predetermined inclusion and exclusion
riteria. Children who met  the ﬁnal diagnosis for ALRTI had at least
 of the following: fever, tachypnoea, cough, auscultation ﬁndings
ndicative of lower respiratory disease (including rhonchi, crack-
es, or bronchial breath sounds) and/or chest retraction supported
ith chest radiographic changes, if available, were included and
f nasopharangeal specimens were collected within 24 h of admis-
ion. Children who had one of the followings were excluded from
he study: congenital or acquired immunosuppressive conditions
nd patients with conditions posing a potential hazard in obtain-
ng the nasopharyngeal samples. A standardized study protocol
as developed to record demographic and medical history of the
atients, clinical features including symptoms and signs, outcome
f the illness and hospital course, and laboratory and radiological
ndings. At the end of the hospitalization, the children’s charts were
eviewed by four of the co-investigators and the clinical diagnosis
as determined by the principal investigator. The clinical diagno-
is was categorized into pneumonia, bronchiolitis, and post-viral
heeze.
.2. Virus detection
During the ﬁrst 24 h of admission, nasopharyngeal aspirates
NPA) were taken from each patient. Viral genome was extracted
sing MagMAX Viral RNA Isolation Kit (Applied Biosystems, CA,
SA). Detection of HRV was performed via reverse transcription on
NA extracts using RevertAid H Minus First Strand cDNA synthe-
is kit (Fermentase, USA). PCR was performed for all the samples
sing primers that ampliﬁed a fragment encompassing the VP4/VP2
egion and the hyper-variable region in the 5′-NCR of human
hinoviruses [9]. Both strands of PCR products were sequenced
sing ABI 3730 xl DNA Analyzer (Applied Biosystems). Specimens
ere also being tested for respiratory syncytial virus (RSV), human
etapneumovirus (HMPV), inﬂuenza virus (IFV) type A and B,
arainﬂuenzavirus 1–4 (PIV1-4), coronaviruses (HCoV) OC43 and
29E [10], human bocavirus (HBoV) and human adenovirus (HAdV)
sing PCR [11,12].
.3. Sequence analysis
Raw sequence data were analyzed using Vector NTI Suite 10
Invitrogen Corp., Carlsbad, CA, USA), assembled using Contig
xpress and aligned using AlignX software. Multiple sequence
lignments were made utilizing MEGA4 software [13] with default
arameters followed by manual editing. Phylogenetic tree was
stimated with MEGA4 using neighbor-joining method [14] with
aximum composite likelihood model with 1000 bootstrap repli-
ates [15]. The nucleotide and deduced amino acid sequences
f the VP4/VP2 regions were compared with those of HRV-A,
RV-B and HRV-C strains using reference sequences available in
he GenBank using BLAST (Basic Local Alignment Search Tool –
ttp://blast.ncbi.nlm.nih.gov/). The sequences generated in this
tudy were submitted to GenBank under accession numbers
M044162 to HM044201.HRV  + RSV + HBoV 1 5.5
HRV  + FluA + HAdV 2 11.1
3.4. Statistical analysis
Demographic and clinical parameters were compared between
HRV, RSV, and IFV-A mono infections and also among HRV
species. Pearson chi-square or Fisher’s exact test were used
for categorical variables. The student’s independent sample t-
test or non-parametric Mann–Whitney U test, ANOVA tests or
Kruskal–Wallis test were applied for continuous variables where
it’s applicable. All analyses were performed using SPSS version 16.0.
p-Values of <0.05 were considered statistically signiﬁcant.
4. Results
4.1. Occurrence of the viruses
A total of 165 children <5 years of age who fulﬁlled the inclusion
criteria were enrolled in the study. RSV (49/165, 29.7%) was found
to be the main single virus detected from the study population,
followed by HRV (36/165, 21.8%) and IFV-A (10/165, 6.1%). Multiple
HRV infections were found in 18 samples (10.9%), including 14 in
dual and 4 in triple infections as shown in Table 1. Of these, dual
infection of HRV and RSV (11/18, 61.1%) was the most prevalent
multiple infection recorded. In total, 54 out of 165 (32.7%) samples
were found infected with HRV.
Out of 36 HRV single infections, 25 (69.4%) were male. The mean
age of HRV patients was  11.8 ranging from 2.0 to 45.1 months. They
were older than children infected with RSV and younger than IFV-A
patients (mean age of 9 and 12.7 months respectively). The mean
age of HRV-C infections was signiﬁcantly higher than HRV-A infec-
tions (16.3 vs. 7.1 months). The majority of the HRV-A infections
were found in children of 6–11 months of age; while the peak age
of patients hospitalized with HRV-C was 12–23 months.
4.2. Clinical features of HRV infections vs. RSV and IFV-A
infections
The clinical features of children infected with HRV, RSV and
IFV-A are shown in Table 2. HRV infected patients were admitted
earlier compared to RSV and inﬂuenza; children with HRV pre-
sented to the hospital after a mean duration of 1.9 days (ranged
1–9 days) as compared with HRV (4.0 days, p = <0.001) and IFV-A
(4.8 days, p = 0.002). In terms of respiratory features, there were
no distinctive differences among the three infections. However,
fever occurred less often in HRV infections than in RSV and IFV-
A. Temperature equal or above 38 ◦C was presented in 17% of HRV
as compared with 33% of RSV and 30% of IFV-A infections. Major-
ity of the HRV patients were hospitalized for shorter duration and
received less antibiotic, particularly in comparison to RSV. Disease
severity characterized by need of oxygen, admission to intensive
care unit (only one case of HRV) and prolonged hospital stay did
not differ among the studied virus groups. Diarrhea was less com-
mon  in HRV single infections as compared with IFV-A (8.3% vs. 40%,
respectively, p = 0.031). Leukocytosis occurred signiﬁcantly more
frequently in HRV single infections than in RSV (p = 0.035). Differ-
ential count showed neutrophilic predominance in HRV compared
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Table 2
Demographic and clinical characteristics of RSV, HRV, and IFVA single infections.
Variables RSV HRV IFVA p-Value
(n = 49) (n = 36) (n = 10)
Demographic characteristics
Gender, male 32 (65.3) 25 (69.4) 6 (60) 0.257
Mean age (months) 9 ± 7.3 11.8 ± 10.3 12.67 ± 8.4
Age  groups
0–5 21 (42.9) 8 (22.2) 2 (20) 0.047; HRV vs. RSV
6–11  14 (28.6) 17 (47.2) 3 (30)
12–23 11 (22.4) 7 (19.4) 4 (40)
24–59 3 (6.1) 4 (11.1) 1 (10)
Clinical characteristics
DOSa,b 4.0 ± 3.5 1.9 ± 2.1 4.8 ± 2.7 <0.001c; HRV vs. RSV; 0.002c; HRV  vs. IFV A
Fever  44 (91.8) 24 (66.7) 10 (100) 0.003d; HRV  vs. RSV; 0.044e; HRV  vs. IFV A
Cough 45 (100) 36 (100) 10 (100) 0.570d
Rhinorrhea 44 (89.8) 28 (77.8) 9 (90) 0.162d
Difﬁculty breathing 42 (85.7) 32 (88.9) 8 (80) 0.733d
Chest crepitation 44 (89.8) 30 (83.3) 10 (100) 0.319
Rhonchi 29 (59.2) 23 (63.9) 6 (60) 0.977
Vomiting 23 (46.9) 20 (55.6) 6 (60) 0.815
Diarrhea 7 (14.3) 3 (8.3) 4 (40) 0.031d; HRV  vs. IFV A
Laboratory ﬁndings
Hemoglobin (g/dL) 11.2 ± 1.3 11.4 ± 1.4 11.3 ± 1.2 0.934
WBC  ≥ 15.0 (×109 cells/L) 6 (12.2) 13 (37.1) 1 (10) 0.035f; RSV vs. HRV
>7.5  (×109 cells/L) 7 (14.3) 13 (37.1) 2 (20) 0.015d; RSV vs. HRV
Platelet (109/L) 360 ± 105 398 ± 139 368 ± 142 0.488
Abnormal chest X-ray 23 (46.9) 14 (40.0) 4 (57.1) 0.747
Hospital course
Duration of hospitalization
1–2 days 6 (12.8) 6 (17.6) 2 (20) 0.011; RSV vs. HRVd
3–4 days 16 (34.0) 21 (61.8) 4 (40)
≥5  days 25 (53.2) 7 (20.6) 4 (40)
Antibiotic therapy 41 (87.2) 22 (64.7) 8 (80) 0.016; RSV vs. HRVd
Clinical diagnosis
Pneumonia 34 (69.4) 23 (63.9) 8 (80) 0.611d
Bronchiolitis 13 (26.5) 8 (22.2) 2 (20) 0.853d
Post-viral wheeze 2 (4.1) 5 (13.9) 0 0.149e
The bold values represent signiﬁcant results.
a Duration from onset of symptoms to admission.
b All the values are presented as mean ± SD.
c Mann–Whitney U test.
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e Fisher’s exact test.
f The Kruskal–Wallis one-way analysis of variance was used.
ith RSV patients (p = 0.015). Pneumonia was the most common
ischarge diagnosis among HRV patients followed by bronchiolitis
nd post-viral wheeze.
.3. Clinical features of HRV-A vs. HRV-C infections
Vomiting occurred almost two times more with HRV-C151 infec-
ion (p = 0.036), as shown in Table 3. HRV-C patients were more
ikely to present with rhonchi in comparison to HRV-A (86% vs. 47%,
espectively, p = 0.024). The study also showed that HRV-C patients
ended to have a higher neutrophil count (p = 0.032) while lympho-
ytosis was associated with HRV-A (p = 0.009). Post-viral wheeze
as more common with HRV-C infections. Disease severity char-
cterized by need of oxygen, admission to intensive care unit (only
ne case of HRV) and prolonged hospital stay did not differ among
he studied species.
.4. Phylogenetic analysis
HRV single infections were subjected to sequencing as the
tudy aimed at looking into different variables of the single infec-
ions. Thirty-three of 36 HRV single samples were retrieved in
equencing. Additionally three HRV samples co-infected with other
iruses were also sequenced. All 36 genetically typed HRV strainsclustered close to a previously reported clinical strain in GenBank,
except strain P51 which became the ﬁrst reported representative of
HRV98. HRV-A strains represented the majority detection (22/36,
61.1%) as shown in Fig. 1. They grouped along with prototype strains
into 15 different serotypes including 12 (5), 22 (1), 24 (3), 32 (1),
34 (1), 39 (1), 41 (1), 43 (1), 46 (1), 47 (1), 56 (2), 62 (1), 89 (1), 98
(1), and 101 (1). We  found that 14 (39%) of the samples were clus-
tered in the separate clad distinct from HRV-A and HRV-B, along
with representative strains of HRV-C (Fig. 2). HRV-B strains were
not among the typed strains. The nucleotide similarities to clos-
est prototype strain in HRV-A, varied from 85.1% to 95.0%, while
the closest genetic relatives were observed with a variation range
of 91.2% to 99.8%. The respective HRV-C strain similarities var-
ied from 87.5% to 98.9%. Genetic analysis used for typing revealed
four human enterovirus (HEV) strains in species HEV-B, HEV-C and
HEV-D. However, it should be noted here that the VP4/VP2 region
used for genetic typing of HRV strains does not unequivocally allow
typing of HEV strains due to greater sequence similarity between
strains within species.5. Discussion
A signiﬁcant burden of HRV infection, was found in 54 out of
165 patients (33%), and this concurs with previous studies with a
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Fig. 1. Neighbor-joining dendrograms depicting phylogenetic relationships of human rhinovirus species A strains of this study in the 420 nucleotide region in VP4/VP2.
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eferences to color in this ﬁgure legend, the reader is referred to the web version of
ate varying from 26% to 33% in a hospitalized pediatric patient
8,16–20]. This contradicts with the traditional notion that HRV
s only associated with upper respiratory tract infections. Ear-
ier studies indicated that the clinical value of positive PCR is
omewhat disputable among patients with ALRTI [3,7,19,21] as
symptomatic HRV infections is known to occur in 15–30% of indi-
iduals. Several subsequent clinical studies of small numbers of
elected patients showed that HRV can replicate in lower respira-
ory tract. This ﬁnding concluded that detection of HRV especially
n children less than 2 years does not simply represent asymp-
omatic infection but is related to true infection [7,22]. In addition,
he ability of HRV to infect lower respiratory airways and to induceranches showing >70% bootstrap support are indicated. (For interpretation of the
rticle.)
cytotoxicity to bronchial epithelium has been shown experimen-
tally among immunocompetent individuals [18].
In this study the most prevalent combination was found
between HRV and RSV. The combination of HRV and RSV as a main
double infection has been reported by others [16,18,23,24]. High
incidence of HRV coupled with RSV infection could be explained by
the substantial overlapping of monthly distribution observed for
these 2 viruses during the study period [23].The relatively recent application of molecular study of PCR
based methods for HRV has identiﬁed several novel HRVs, includ-
ing HRV-C. Our study showed that HRV-B was absent while HRV-A
predominates from HRV-C. This ﬁnding seems to reinforce that
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RV-B is a minor species worldwide; however it concurs with most
ndings by other investigators as HRV-A was the most prevalent
ompared to the other species. This may  reﬂect apparent seasona-
ity or yearly variation of circulating HRV. On the other hand, it may
e associated with HRV-B of a milder form of disease presentation
nd consequent of lesser rate of hospitalization.
Consistent with other ﬁndings, our study showed that HRV
nfected children are older than those with RSV infections and
ounger than those with IFV-A infections [25,8]. The results support
he importance of HRV infections among infants with acute respira-
ory infections [3,22] especially in its second half. HRV-A infections
ere more likely to occur during infancy as compared with HRV-C,
urther corroborating the ﬁndings that HRV-A infections are less
revalent in older age group as compared with HRV-C [26,27].
Few studies have described the clinical characteristics of HRV
LRI in infants and young children. Our study revealed that HRV
nfected children were hospitalized earlier in the course of theirinovirus species C strains of this study in the 420 nucleotide region in VP4/VP2.
Branches showing >70% bootstrap support are indicated. (For interpretation of the
rticle.)
disease and were less febrile on presentation as compared to RSV
and IFV-A infections. They were also more likely to be discharged
earlier and tend to receive lesser antibiotics as compared to the
other two infections, especially to RSV. HRV is known to have a
shorter incubation period and hence presented earlier as compared
with HRV or occasionally with IFV-A especially with H1N1 infec-
tion. This could be explained further in terms of the cytopathology
on the respiratory epithelial cells as HRV is the least invasive with
minimal cell damage and secondary bacterial infection is far less a
complication compared to RSV and IFV. As a result, patients were
subjected to lesser antibiotics and stayed shorter in the hospital
as seen in this study. However, neutrophilia as documented in the
present study may  not reﬂect secondary bacterial infection in HRV.
Several studies in the past, acknowledged the increase infection in
both peripheral and airway neutrophils as a risk to development of
asthmatic exacerbations. On the other hand, IFA-A infection tended
to be associated with diarrhea, as the infection usually resulted in
676 M.R. Etemadi et al. / Journal of Clinica
Table 3
Clinical characteristics of HRV-A and HRV-C single infections.
Variables HRV-A HRV-C p-Value
(n = 19) (n = 14)
Demographic characteristics
Gender, male 15 (78.9%) 8 (57.1%) 0.178
Mean age (months)
Age groups 7.1 ± 3.8 16.3 ± 11.0 0.01
0–5  6 (31.6) 2 (14.3) 0.007
6–11  11 (57.9) 4 (28.6)
12–23 2 (10.5) 5 (35.7)
24–59 0 3 (21.4)
Clinical characteristics
Fever 14 (73.7) 8 (57.1) 0.459
Cough 19 (100) 14 (100) 0.67
Rhinorrhea 15 (78.9) 10 (71.43) 0.695
Difﬁculty breathing 17 (89.5) 13 (92.9) 1
Vomiting 8 (42.1) 11 (78.6) 0.036
Chest recession 16 (84.2) 13 (92.9) 0.62
Chest crepitation 15 (78.9) 13 (92.9) 0.366
Rhonchi 9 (47.4) 12 (85.7) 0.024
Laboratory ﬁndings
WBC  ≥ 15.0 (×109 cells/L) 6 (31.6) 5 (38.5) 0.721
ANC (×109 cells/L) 4.6 ± 2.5 7.3 ± 4.3 0.032c
ALC (×109 cells/L) 7.3 ± 3.8 4.5 ± 1.8 0.009d
Platelet (109/L) 417 ± 135 348 ± 126 0.157c
Hospital course
Mean DOHa,b 4.18 ± 2.430 4.07 ± 1.439 0.554d
Antibiotic therapy 10 (58.8) 10 (71.4) 0.707e
Supplemental O2 14/17 (82.4) 11/13 (84.6) 1.000e
Underlying disease
Asthma 3 (15.8) 1 (7.1) 0.451
Clinical diagnosis
Pneumonia 12 (63.2) 9 (64.3) 0.947e
Bronchiolitis 6 (35.3) 2 (14.3) 0.241e
Post-viral wheeze 1 (5.9) 3 (21.4) 0.158e
Normal ranges (Reference: International Federation of Clinical Chemistry (IFCC)):
WBC: 4.5–13.5; neutrophil: 2.0–6.0; lymphocyte 5.5–8.5; platelet: 150–400. The
bold values represent signiﬁcant results.
a Duration from onset of symptoms to admission.
b All the values are presented as mean ± SD.
c t-Test was  used.
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[4] Juven T, Mertsola J, Waris M.  Etiology of community-acquired pneumonia in 254d Mann–Whitney test was used.
e Fisher’s exact test.
 more systemic involvement with direct invasion of the gastroin-
estine by the virus [28].
This study further distinguishes certain clinical features of the
wo species of HRV in ALRTI. Although in general, the clinical
resentations were comparable for both HRV-A and C, rhonchi
nd vomiting were more common in HRV-C infected children as
ompared to HRV-A. In our study, the presence of rhonchi was
ssociated with ALRTI rather than asthma, as only one had asthma
s an underlying disease. As shown in previous studies, this ﬁnd-
ng further supports the role of HRV-C among patients with febrile
heeze in ALRTI. A large clinical cohort study indicated that this
roup of children has a preexisting predisposition to asthma in
arly childhood. On the other hand, vomiting has not been reported
n other studies as a prominent presentation in HRV-C. Vomiting
ith coughing is common in children (post-tussive vomiting) and it
ould be related to the wheezing episodes in our study and indicate
 more severe form of infection in HRV-C as compared to HRV-A.
ikewise, no characteristic laboratory ﬁnding has been associated
reviously with any speciﬁc HRV species; the modest increase in
ymphocytes in HRV-A and neutrophils in HRV-C in our study could
e coincidental and probably of no clinical importance. Consistent
ith the study by Jin [29], there was no signiﬁcant difference in
erms of disease severity for both species of HRV. On the other
and, Miller [8] found that HRV-C patients were more likely tol Virology 58 (2013) 671– 677
require supplemental oxygen than HRV-A. The variations could be
partly attributed to bacterial co-infections, viral load and type of
the studied population. Therefore, these data must be interpreted
with some caution.
Several different types were detected including outbreak-like
clusters, e.g. HRV12. Phylogenetic analysis conﬁrmed global preva-
lence of HRV-C strains. This study showed the large variation of
concomitantly circulating HRV strains as reported previously [30].
Due to increased sequence typing efforts during recent years, most
of the HRV strains of this study were shown to have very close
genetic relatives circulating in other geographical areas.
In this study, HRV has been implicated as a cause of hospitaliza-
tion in children with ALRTI in our locality. The dominant presence
of both HRV-A and C concurs with global epidemiologic studies in
other parts of the world. There were also some differences between
the demographic variables, clinical manifestations and laboratory
ﬁndings of HRV, RSV and IFV-A infections and within the HRV
species. However, corroboration of the clinical signiﬁcance and its
pathogenesis will require larger numbers of subjects and should
include a control group with no respiratory infection. The study
could not be generalized as only it involved small numbers and
in-patients are involved. A prospective longitudinal multicenter
population based studies, utilizing quantitative PCR methods, are
needed to better explore and understand the role of HRV in ALRTIs.
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